Section Arrow
ACHV.NASDAQ
- Achieve Life Sciences
Quotes are at least 15-min delayed:2026/05/09 13:53 EDT
Regular Hours
Last
 5.21
+0.42 (+8.77%)
Day High 
5.35 
Prev. Close
4.79 
1-M High
5.3 
Volume 
1.76M 
Bid
5.22
Ask
5.23
Day Low
4.74 
Open
4.81 
1-M Low
3.1 
Market Cap 
491.74M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.37 
20-SMA 4.23 
50-SMA 3.97 
52-W High 6.025 
52-W Low
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.25/-0.90
Enterprise Value
502.93M
Balance Sheet
Book Value Per Share
0.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TRAWTraws Pharma Inc2.18+0.48+28.24%2.07PE
VRAXVirax Biolabs Group Limited0.171+0.036+26.67%-- 
ASBPAspire Biopharma Holdings Inc.0.185+0.03+19.35%-- 
INOInovio Pharmaceuticals1.46+0.09+6.57%-- 
MRNAModerna54.35+5.81+11.97%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.